The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the pharmacokinetics, pharmacodynamics, and
pharmacogenomics of dexmedetomidine in the following three pediatric patient populations:
patients with bi-directional cavopulmonary anastomosis or a Fontan procedure, patients who
have had a cardiac transplant, and patients with otherwise normal physiology who are
undergoing closure of a patent ductus arteriosis or atrial septal defect.
Phase:
Phase 3
Details
Lead Sponsor:
Children's National Research Institute Children's Research Institute